Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 626

1.

Conventional drug therapy for inflammatory bowel disease.

Bryant RV, Brain O, Travis SP.

Scand J Gastroenterol. 2015 Jan;50(1):90-112. doi: 10.3109/00365521.2014.968864.

PMID:
25523560
[PubMed - in process]
2.

Patients' assessment of adalimumab self-injection for Crohn's disease: a multicenter questionnaire survey (The PEARL Survey).

Hirai F, Watanabe K, Matsumoto T, Iimuro M, Kamata N, Kubokura N, Esaki M, Yamagami H, Yano Y, Hida N, Nakamura S, Matsui T.

Hepatogastroenterology. 2014 Sep;61(134):1654-60.

PMID:
25513143
[PubMed - in process]
3.

Risk of infections associated with biological treatment in inflammatory bowel disease.

Andersen NN, Jess T.

World J Gastroenterol. 2014 Nov 21;20(43):16014-16019. Review.

PMID:
25473153
[PubMed - as supplied by publisher]
Free PMC Article
4.

Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis.

Hazlewood GS, Rezaie A, Borman M, Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA, Melmed GY, Kaplan GG.

Gastroenterology. 2014 Oct 16. pii: S0016-5085(14)01268-2. doi: 10.1053/j.gastro.2014.10.011. [Epub ahead of print]

PMID:
25448924
[PubMed - as supplied by publisher]
5.

Comparative Efficacy of Biologic Therapy in Biologic-Naïve Patients With Crohn Disease: A Systematic Review and Network Meta-analysis.

Singh S, Garg SK, Pardi DS, Wang Z, Hassan Murad M, Loftus EV Jr.

Mayo Clin Proc. 2014 Dec;89(12):1621-35. doi: 10.1016/j.mayocp.2014.08.019. Epub 2014 Oct 29.

PMID:
25441399
[PubMed - in process]
6.

Patients' assessment of adalimumab self-injection for Crohn's disease: a multicenter questionnaire survey (The PEARL Survey).

Hirai F, Watanabe K, Matsumoto T, Iimuro M, Kamata N, Kubokura N, Esaki M, Yamagami H, Yano Y, Hida N, Nakamura S, Matsui T.

Hepatogastroenterology. 2014 Sep;61(134):1654-60.

PMID:
25436358
[PubMed - in process]
7.

Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy.

Khan N, Asim H, Lichtenstein GR.

Expert Opin Drug Saf. 2014 Dec;13(12):1699-708. doi: 10.1517/14740338.2014.973399.

PMID:
25406728
[PubMed - in process]
8.

Safety considerations when using anti-TNFα therapy to treat Crohn's disease.

Pagnini C, Arseneau KO, Cominelli F.

Expert Opin Drug Saf. 2015 Jan;14(1):31-44. doi: 10.1517/14740338.2015.976610. Epub 2014 Nov 15.

PMID:
25400161
[PubMed - in process]
9.

Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease - clinical observations from a tertiary Eastern European center.

Bor R, Farkas K, Bálint A, SzŰcs M, Abrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.

Scand J Gastroenterol. 2014 Nov 11:1-6. [Epub ahead of print]

PMID:
25384713
[PubMed - as supplied by publisher]
10.

Detection of Adalimumab and Anti-Adalimumab Levels by ELISA: Clinical Considerations.

Marinari B, Botti E, Bavetta M, Spallone G, Zangrilli A, Talamonti M, Richetta A, Chimenti S, Costanzo A.

Drug Dev Res. 2014 Nov;75 Suppl 1:S11-4. doi: 10.1002/ddr.21186.

PMID:
25381966
[PubMed - in process]
11.

Dose tailoring of anti TNF-α therapy delivers useful clinical efficacy in Crohn's Disease patients experiencing loss of response.

Ghaly S, Costello S, Beswick L, Pudipeddi A, Agarwal A, Sechi A, Antoniades S, Headon B, Connor S, Lawrance IC, Sparrow M, Walsh AJ, Andrews JM; On behalf of AIBDA.

Intern Med J. 2014 Nov 5. doi: 10.1111/imj.12621. [Epub ahead of print]

PMID:
25370691
[PubMed - as supplied by publisher]
12.

Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease.

Aggarwal D, Limdi JK.

Eur J Gastroenterol Hepatol. 2015 Jan;27(1):13-9. doi: 10.1097/MEG.0000000000000222.

PMID:
25341058
[PubMed - in process]
13.

Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first "real-life" experience in primary gastroenterology centers in Italy.

Tursi A, Elisei W, Picchio M, Penna A, Forti G, Giorgetti GM, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G.

Ann Gastroenterol. 2014;27(4):369-373.

PMID:
25331091
[PubMed - as supplied by publisher]
Free PMC Article
14.

Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?

Akobeng AA, Sandborn WJ, Bickston SJ, Chande N, Shackelton LM, Nelson S, Feagan BG.

Inflamm Bowel Dis. 2014 Nov;20(11):2132-41. doi: 10.1097/MIB.0000000000000218.

PMID:
25299543
[PubMed - in process]
15.

[Follow-up of patients with inflammatory bowel disease: developments presented at Digestive Disease Week 2014].

García-López S.

Gastroenterol Hepatol. 2014 Sep;37 Suppl 3:31-9. doi: 10.1016/S0210-5705(14)70081-0. Spanish.

PMID:
25294264
[PubMed - in process]
16.

Adalimumab Therapy in Children With Crohn's Disease Previously Treated With Infliximab; A Dutch Nationwide Cohort Study.

Cozijnsen M, Duif V, Kokke F, Kindermann A, van Rheenen P, de Meij T, Schaart M, Damen G, Norbruis O, Pelleboer R, Van den Neucker A, van Wering H, Hummel T, Oudshoorn J, Escher J, de Ridder L; the Dutch PIBD working group: Kids with Crohn and Colitis (KiCC).

J Pediatr Gastroenterol Nutr. 2014 Oct 2. [Epub ahead of print]

PMID:
25286063
[PubMed - as supplied by publisher]
17.

Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.

Tursi A, Elisei W, Principi M, Inchingolo CD, Nenna R, Picchio M, Giorgio F, Ierardi E, Brandimarte G.

J Gastrointestin Liver Dis. 2014 Sep;23(3):261-5. doi: 10.15403/jgld.2014.1121.233.we2.

PMID:
25267953
[PubMed - in process]
Free Article
18.

Management of inflammatory bowel disease in poor responders to infliximab.

Guerra I, Bermejo F.

Clin Exp Gastroenterol. 2014 Sep 18;7:359-67. doi: 10.2147/CEG.S45297. eCollection 2014. Review.

PMID:
25258548
[PubMed]
Free PMC Article
19.

Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study.

Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S.

Clinicoecon Outcomes Res. 2014 Sep 18;6:401-7. doi: 10.2147/CEOR.S66338. eCollection 2014.

PMID:
25258545
[PubMed]
Free PMC Article
20.

An update on disease modifying antirheumatic drugs.

Joshi P, Dhaneshwar SS.

Inflamm Allergy Drug Targets. 2014;13(4):249-61.

PMID:
25244345
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk